Access cutting-edge her2+ cancer treatment through this clinical trial at a research site in Harrison. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Harrison location
Access her2+ cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related her2+ cancer treatment provided free
Check if you qualify for this her2+ cancer clinical trial in Harrison, NY
No-Cost Study Care
Local to Harrison
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study to see how the brain absorbs, distributes, and gets rid of tucatinib in people who have HER2+ cancers (breast cancer, NSCLC, CRC, or GEC) that have spread to the brain, and to learn more about how cancer cells develop resistance to treatment. The researchers will do research tests to look for genetic differences between HER2+ breast cancer that has spread to the brain and progressed during treatment with tucatinib and cancers that are being treated with tucatinib for th
Sponsor: Memorial Sloan Kettering Cancer Center
Yes, this clinical trial (NCT05892068) has an active research site in Harrison, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for her2+ cancer treatment options in Harrison, NY, this clinical trial (NCT05892068) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Harrison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced her2+ cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all her2+ cancer clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in Harrison — not just this study.
Browse Breast Cancer Trials in Harrison →